Abstract:Erythermalgia is a distinctive clinical entity characterized by local redness, warmth, and burning pain in the distal portions of the extremities. In this study, erythemalgia was observed in two patients with myeloproliferative disease. A new theory suggesting abnormally rapid platelet aggregation as a cause of erythermalgia was advanced. The following evidence is presented: (1) histologic evidence of thrombi occluding the arterioles and probably composed of platelet aggregates; (2) reversal of the clinical fi… Show more
“…About 20% of cases are associated to hematological malignancies, such as thrombocythemia or polycythemia (38), and the average span between disease occurrence and the diagnosis of neoplasm is estimated in 2.5 years. In these secondary cases, it is thought that platelet breakdown products and platelet‐rich microthrombi may be the basis of the disease (39).…”
Paraneoplastic syndromes are localized or diffuse pathologic manifestations that may occur in subjects affected by neoplastic diseases, even occult ones. Among the many clinical manifestations of paraneoplastic syndromes, cutaneous ones are quite common. It is estimated that skin manifestations may represent the very first diagnostic sign of a neoplastic disease in about 1% of patients. Many paraneoplastic syndromes with skin manifestations are caused by vascular alterations. In case of solid tumors, migrant thrombophlebitis and blood hypercoagulability can be seen, whereas in case of hematological neoplasms, vasculitis, and erythromelalgia can occur. Paraneoplastic vasculitis and paraneoplastic vascular syndromes are challenging issues in dermatology and general medicine. The present article will review the actual knowledge in the argument, together with providing hints for its diagnosis and management.
“…About 20% of cases are associated to hematological malignancies, such as thrombocythemia or polycythemia (38), and the average span between disease occurrence and the diagnosis of neoplasm is estimated in 2.5 years. In these secondary cases, it is thought that platelet breakdown products and platelet‐rich microthrombi may be the basis of the disease (39).…”
Paraneoplastic syndromes are localized or diffuse pathologic manifestations that may occur in subjects affected by neoplastic diseases, even occult ones. Among the many clinical manifestations of paraneoplastic syndromes, cutaneous ones are quite common. It is estimated that skin manifestations may represent the very first diagnostic sign of a neoplastic disease in about 1% of patients. Many paraneoplastic syndromes with skin manifestations are caused by vascular alterations. In case of solid tumors, migrant thrombophlebitis and blood hypercoagulability can be seen, whereas in case of hematological neoplasms, vasculitis, and erythromelalgia can occur. Paraneoplastic vasculitis and paraneoplastic vascular syndromes are challenging issues in dermatology and general medicine. The present article will review the actual knowledge in the argument, together with providing hints for its diagnosis and management.
“…Interestingly, there was no evidence of arteriosclerosis. In 1977, Redding 10 described a patient with ET as a cause of erythromelalgia complicated by ischemic acrocyanosis of the little toe. Punch skin biopsies showed occluding thrombi in many capillaries and in some dermal arteries, arterioles, and venules.…”
Section: Histopathology Of Erythromelalgiamentioning
Erythromelalgia is a characteristic thrombotic complication in patients with the myeloproliferative disorders, essential thrombocythemia and polycythemia vera. In this minireview, which is based on more than 20 years of clinical observations and intervention studies, the clinical manifestations, treatment, and pathogenesis of erythromelalgia are discussed.
“…Perhaps the most frequent feature is cyanosis and purple coloration of the face. About 15% of the patients present with pruritus, 1 3% with erythromelalgia 2 . Aquagenic pruritus, 3 urticaria vasculitis, 4 repeated attacks of erythromelalgia 5 were described as initial features of PV.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.